Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
US Army
Boehringer Ingelheim
Medtronic
Chinese Patent Office
Baxter
Accenture
Dow
UBS
McKinsey

Generated: February 18, 2018

DrugPatentWatch Database Preview

CARDIZEM Drug Profile

« Back to Dashboard

Which patents cover Cardizem, and what generic alternatives are available?

Cardizem is a drug marketed by Biovail, Biovail Labs Intl, and Valeant Intl. and is included in six NDAs. There are two patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in CARDIZEM is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

US Patents and Regulatory Information for CARDIZEM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail CARDIZEM SR diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019471-004 Jan 23, 1989 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Biovail CARDIZEM diltiazem hydrochloride INJECTABLE;INJECTION 020792-001 Sep 5, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-003 Feb 6, 2003 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-006 Feb 6, 2003 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Valeant Intl CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-004 Dec 8, 1986 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-001 Nov 5, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020062-005 Aug 24, 1999 AB3 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-004 Feb 6, 2003 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Valeant Intl CARDIZEM CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020062-001 Aug 10, 1992 AB3 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-004 Feb 6, 2003 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CARDIZEM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Intl CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-004 Dec 8, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-001 Nov 5, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-004 Dec 8, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-002 Nov 5, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-003 Dec 8, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Intl CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-004 Dec 8, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for CARDIZEM
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Extended-release Tablets 120 mg, 180 mg, 240 mg, 300 mg and 360 mg ➤ Subscribe 8/30/2005
➤ Subscribe Extended-release Tablets 420 mg ➤ Subscribe 4/25/2005

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fuji
Queensland Health
Dow
Boehringer Ingelheim
Federal Trade Commission
QuintilesIMS
Medtronic
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot